JHOP - June 2018 Vol 8, No 2

Ákos Juhász, PharmD, and colleagues, suggest that the use of a closed-system drug-transfer device to reduce the high levels of cytotoxic drugs would reduce the levels of contamination found in hospital pharmacies.

The approved uses of oncology treatments are generally based on the cancer site, cancer stage, disease characteristics, and line of therapy. Concerns have been raised about the appropriateness of off-label use of drugs in oncology, particularly with novel, high-cost agents.

In a review of studies examining tobacco use among patients diagnosed with cancer, the rate of patients who were smokers at the time of their cancer diagnosis ranged from 46% to 75%. Among the patients who were smokers at diagnosis, the reviewers estimated that up to 58% of patients continued to smoke after initiating cancer therapy.

Results 1 - 4 of 4